Additionally, PRL has been shown to have antitumorigenic effects in BC cells that overexpress HER-2 by suppressing the epithelial-mesenchymal transition process; it also decreased the potential for malignancy by promoting cell adhesion and suppressing proliferation, tumor initiation/growth, drug resistance, tumorsphere formation capacity, and invasion of BC cells. This evidence concerns the gene PRL and breast cancer.